Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial examining the safety, tolerability, and exploratory efficacy of IMS001 in adults with multiple sclerosis; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• IMS001

Snippet

Sponsor: ImStem Biotechnology | Conditions: Multiple Sclerosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING